ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,624,000 | -54.3% | 2,024,400 | -43.0% | 0.15% | -54.0% |
| Q1 2021 | $18,851,000 | -1.5% | 3,550,000 | 0.0% | 0.33% | -1.2% |
| Q4 2020 | $19,135,000 | -78.2% | 3,550,000 | -67.7% | 0.33% | -73.5% |
| Q3 2020 | $87,780,000 | -12.4% | 11,000,000 | +7.8% | 1.25% | -37.0% |
| Q2 2020 | $100,170,000 | +2871.5% | 10,200,000 | +5446.5% | 1.98% | +113.4% |
| Q2 2015 | $3,371,000 | – | 183,900 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |